Brazil Pharmaceuticals Market Outlook to 2025: Ken Research
by Rati Ram Business DeveloperThe report titled “Brazil
Pharmaceuticals Market Outlook to 2025 - By International and Domestic
Companies, By Retail and Institutional Sales, By Institutional Sales
(Public, Private and Others), By Drug Type (Prescription, Over-The-Counter and
Generics), By Generic Drug Type (Branded and Local), By Region (Southeast,
South, Northeast, Midwest and North), By Therapeutic Areas” provides a comprehensive analysis of
the Pharmaceuticals market in Brazil. The report also covers the overview and
genesis, market size in terms of Revenue, trends and developments, issues and
challenges and regulations in Brazil. The report provides value chain, competitive
scenario and company profiles of the major players operating in Brazil. The
report concludes with market projection and analyst recommendations
highlighting the major opportunities and cautions.
Brazil Pharmaceuticals Market Overview
and Size
Brazil Pharmaceuticals market in terms of revenue increased
at a double digit CAGR during the review period 2013-2018. The market was
observed to be at growth stage owing to growing intensity of competition among
the domestic and international manufacturers in the market which allows them to
invest heavily in Research and Development and provides wide offering of
patented and generic drugs in Prescription and Over-The-Counter form in the
country. In Brazil, the number of growing chronic diseases and per capita
healthcare expenditure to spend on the medications will improve the revenues of
Pharmaceuticals Market over the years in Brazil.
The market is booming with the Universal Health System,
growing elderly population, huge investment in R&D for new drugs, reduced
time in the manufacturing approval process, increasing government health
expenditure, acquisitions of brands to expand in different regions and segments
coupled with per capita income of individuals in Brazil.
Brazil Pharmaceuticals Market
Segmentation
By International and Domestic Companies:
Brazil is moderately
fragmented market with the presence of many International and Domestic players.
International Companies dominates the sales volume of patented drugs whereas
the domestic companies are largely involved in the production of Generic drugs
in terms of sales volume. On the other hand, patented drugs are largely
expensive and generate comparatively higher revenues than the generics.
Moreover, International companies have strong distribution channel to serve
every region in Brazil. Hence, they accounts for a larger share in terms of
revenue in Pharmaceuticals Market in Brazil.
By Distribution Channel: Majority of the revenues are generated from
the retail segment in Brazil. The highest revenue share of retail sales was
largely due to the presence of number of retail outlets in all the areas of
Brazil. Institutional sales on the other hand are driven by the new product innovations
being largely recommended by physician or the doctor.
By Institutional Sales: Public Institutions in Brazil accounted for the highest percentage share in terms of revenue due to the presence of large number of public hospitals in the country and the Hospitals’ own pharmacies that gives the advantage of prescription and OTC medications to the patients. Private Institutions on the other hand accounted for a lower percentage share due to the decline in the number of private hospitals observed over the years.
By Type of Drugs: Prescription drugs accounted for the highest revenue share in terms in the year 2018. Prescription drugs in the market are generally patented drugs being recommended by the doctors and are usually taken for chronic diseases. These medicines are being served among middle to upper class population in Brazil. Higher prices of these medicines generate higher revenues from prescription drugs segment in the country. OTC and Generic drugs on the other hand are affordable by the majority of the population and serve the underpenetrated areas of the country.
By Region: Southeast region in Brazil that includes Sao Paulo and Rio de Janeiro accounted for highest revenue share in 2018 due to the highest population in Brazil, Highest contribution to GDP, diverse pharmaceutical industry and high purchasing power of in that region. Southeast region is followed by South and Midwest region in Brazil due to the high purchasing power of the individuals in that region.
By Therapeutic Areas: Cardiovascular segment accounts for the
highest percentage share in terms of revenue in Brazil largely due the highest number
of deaths being caused by Ischemic Heart Disease among all other causes of
deaths in Brazil. It is followed by Central Nervous System, Respiratory and
Oncology. The manufacturing companies are making oncology as their major
product innovation area in Brazil.
Competitive
Landscape
Pharmaceuticals
Market in Brazil is a moderately fragmented market with presence of domestic
and international players wherein the patented drug manufacturers are mainly
the international companies and generic drug manufacturers are majorly the
domestic ones. Major Domestic Companies include Ache Laboratories, EMS Pharma,
Eurofarma and Hypera Pharma and international companies include Novartis,
Sanofi, Bayer, Abbott Laboratories and many others.
Brazil Pharmaceuticals Market Future
Outlook
In future, it is anticipated that the revenue of
Pharmaceuticals Market in Brazil will be driven by the growing elderly
population (above 65 years), growing prevalent of chronic diseases, increasing
per Capita health expenditure, ease in availability of medicines coupled with growing
number of acquisitions to expand business portfolio, increasing number of Point
of Sale and rising investment in R&D activities.
Key
Segments Covered
By
Type of Companies
International Companies
Domestic Companies
By
Type of Channel
Institutional
Public
Private
Others
Retail
By
Drug Type
Prescription
Over-The-Counter
Generics
Branded
Local
By
Region
Southeast
South
Midwest
Northeast
North
By
Therapeutic Areas
Cardiovascular
Central Nervous System
Respiratory
Oncology
Anti-Infective
Gastrointestinal
Others
Key
Target Audience
Pharmaceutical Manufacturing Companies
Pharmacy Retail Outlets
Government/ Regulatory Authorities Venture Capitalist Firms
Health Insurance Companies
Pharmaceutical Products Distributors
Time
Period Captured in the Report:
Historical Period: 2013-2018
Forecast Period: 2019F-2025F
Companies
Covered:
Major Manufacturers
Ache Laboratories
EMS Pharma
Eurofarma
Sanofi
Novartis
Neo Quimica
Mantecopr Farmasa
Libbs
Biolab- Sanus Farma
Takeda Pharma
Medley
Bayer Pharma
CIMED
Key
Topics Covered in the Report
Brazil Pharmaceuticals Market Overview and Genesis (Overview and Genesis, Business Cycle Graph)
Brazil Pharmaceutical Market Value Chain Analysis
Brazil Pharmaceutical Market Size
Brazil Pharmaceuticals Market Segmentation
Regulatory Landscape in Brazil Pharmaceuticals Market
Trends and Developments in Brazil Pharmaceuticals Market
Issues and Challenges in Brazil Pharmaceuticals Market
Brazil Pharmaceuticals Market Competition Landscape
Cross Comparison of 7 Major Players in Brazil Pharmaceuticals Market
Brazil Pharmaceuticals Market Future Projection, 2018-2025F
Future Outlook of Brazil Pharmaceuticals Market Segmentations, 2018-2025F
Analyst Recommendations
For more information, refer to below link:
Related Reports
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249
Sponsor Ads
Created on Jan 24th 2020 04:38. Viewed 420 times.